Log in
Registration
Українська
English
Search for:
Home
Electronic publication
Fresh number
Archives
Authors
About Edition
Subscription
Requirements for authors
Reviewing
Editorial board
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Rubric : Review Articles
Drugs used as radiosensitizers: clinical and pharmaceutical aspects and prospects (literature review)
Authors: Andrushchenko I.V. Afanasieva I.O. Дата: 2025-06-30
Possibilities of modern visualization methods in planning radiation therapy in patients with cervical cancer
Authors: Ivankova V.S. Domina E.A. Khrulenko T.V. Baranovska L.M.... Дата: 2025-06-27
Management strategy for gastrointestinal stromal tumors (GIST): current status and future perspectives
Authors: Kondratskyi Yu.M. Koval N.O. Kolesnyk A.V. Kozak E.O.... Дата: 2025-06-27
Prognostic factors for successful discontinuation of tyrosine kinase inhibitor treatment in patients with chronic myeloid leukemia
Authors: Tomashevska N.Y. Kotlyarchuk K.B. Korolchuk O.S. Boyko O.I.... Дата: 2025-06-27
Modern approaches to the treatment of advanced ovarian cancer in the 1
st
line therapy (PAOLA-1 study) and recurrent ovarian cancer regardless of the presence of
BRCA
mutations, as well as modern cytoreductive approaches (based on materials from the ESGO 2025 Congress)
Дата: 2025-06-25
Peritoneal carcinomatosis from gastric cancer treatment perspectives. A narrative review
Authors: Pepenin M.O. Kondratskyi Y.M. Dobrzhanskyi O.Y. Kolesnyk A.V.... Дата: 2025-06-19
Subscapular artery system flaps in head and neck reconstructive surgery: literature review and clinical experience
Authors: Fokin H.H. Kravets O.V. Т. 15, №1 (57)
Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: a matching-adjusted indirect comparison
Т. 15, №1 (57)
Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score <1%: pooled analysis of outcomes after five years of follow-up
Т. 15, №1 (57)
Thromboprophylaxis with original enoxaparin in oncology patients
Т. 15, №1 (57)
CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice?
Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56)
Midazolam in modern anesthesiology and intensive care
Authors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56)
Pembrolizumab
vs
Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716
Т. 14, №4 (56)
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Т. 14, №4 (56)
KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanoma
Т. 14, №4 (56)
1
2
3
4
5
...
»
Последняя »